【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Cytoxan
04.1.2 Vidaza
04.1.3 Dacogen
04.1.4 Idamycin PFS
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Understanding the Disease
07.2 Etiology and Risk Factors
07.3 Pathophysiology
07.4 Epidemiology
07.5 Classification
07.5.1 FAB Classification
07.5.2 WHO Classification
07.6 Diagnosis
07.6.1 Blood Samples
07.6.2 Bone Marrow Samples
07.6.3 Spinal Fluid
07.6.4 CBC and Peripheral Smear
07.6.5 Blood Chemistry and Coagulation Tests
07.6.6 Microscopic Exams
07.6.7 Cytochemistry
07.6.8 Flow Cytometry and Immunohistochemistry
07.6.9 Cytogenetics
07.6.10 FISH and PCR
07.6.11 X-Ray
07.6.12 CT Scan
07.6.13 Ultrasound
07.6.14 MRI Scan
07.7 Treatment and Management
07.7.1 Induction Therapy
07.7.2 Post Remission Therapy
07.8 Economic Burden
08.Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09.Market Segmentation by Class of Drugs
09.1 Alkylating Agent
09.2 Cytotoxic Antibiotic
09.3 Topoisomerase Inhibitor
09.4 Others
10.Geographical Segmentation
11.Buying Criteria
12.Market Growth Drivers
13.Drivers and their Impact
14.Market Challenges
15.Impact of Drivers and Challenges
16.Market Trends
17.Trends and their Impact
18.Pipeline Portfolio
19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2014
19.2.1 Celgene
19.2.2 Johnson & Johnson
19.2.3 Pfizer
19.2.4 Bristol Myers Squibb
19.3 Other and Future Prominent Vendors
20.Key Vendor Analysis
20.1 Bristol Myers Squibb
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Business Segmentation
20.1.4 Revenue by Business Segmentation
20.1.5 Revenue Comparison 2013 and 2014
20.1.6 Sales by Geography
20.1.7 Business Strategy
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Celgene
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Business Segmentation
20.2.4 Revenue by Business Segmentation
20.2.5 Revenue Comparison 2013 and 2014
20.2.6 Sales by Geography
20.2.7 Business Strategy
20.2.8 Key Developments
20.2.9 SWOT Analysis
20.3 Johnson and Johnson
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue by Business Segmentation
20.3.5 Revenue Comparison 2013 and 2014
20.3.6 Sales by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Pfizer
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Business Segmentation
20.4.4 Revenue by Business Segmentation
20.4.5 Revenue Comparison 2013 and 2014
20.4.6 Sales by Geography
20.4.7 Business Strategy
20.4.8 Key Developments
20.4.9 SWOT Analysis
23.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Acute Myeloid Leukemia
Exhibit 3: Percentage of Acute Myeloid Leukemia Cases in Comparison with Other Types of Leukemia in the US 2014
Exhibit 4: FAB Classification of Acute Myeloid Leukemia
Exhibit 5: FAB Classification of Acute Myeloid Leukemia and the Percentage of Patients in Each Class
Exhibit 6: Percentage Distribution of Acute Myeloid Leukemia Patients According to the FAB Classification
Exhibit 7: The WHO Classification of Acute Myeloid Leukemia
Exhibit 8: Treatment Options for Acute Myeloid Leukemia
Exhibit 9: Treatment Options for Relapsed Acute Myeloid Leukemia
Exhibit 10: Snapshot of the Economic Burden of Acute Myeloid Leukemia
Exhibit 11: Cost Per Patient in Different Treatment Cycles in the US (2012)
Exhibit 12: Cost Per Patient in Different Treatment Cycles in the UK (2012)
Exhibit 13: Snapshot of the Global Acute Myeloid Leukemia Therapeutics Market, 2014
Exhibit 14: Global Acute Myeloid Leukemia Therapeutics Market 2014-2019 (US$ million)
Exhibit 15: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs
Exhibit 16: Global Acute Myeloid Leukemia Therapeutics Market Segmentation by Class of Drugs 2014
Exhibit 17: Global Acute Myeloid Leukemia Therapeutics Market by Geographical Segmentation 2014
Exhibit 18: Buying Criteria of Global Acute Myeloid Leukemia Therapeutics Market
Exhibit 19: Phase III Pipeline Molecules for Acute Myeloid Leukemia
Exhibit 20: Global Acute Myeloid Leukemia Therapeutics Market Share Analysis 2014
Exhibit 21: Authorization Details of Vidaza
Exhibit 22: Regulatory History of Dacogen
Exhibit 23: Authorization Details of Dacogen
Exhibit 24: Bristol-Myers Squibb: Business Segmentation 2014
Exhibit 25: Bristol-Myers Squibb: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 26: Bristol-Myers Squibb: Sales by Geography (in US$ million)
Exhibit 27: Celgene: Business Segmentation by Revenue 2013 and 2014
Exhibit 28: Celgene: Sales by Geography 2014 (Pharmaceuticals Division)
Exhibit 29: Celgene: Sales by Geography 2014 (Diagnostics Division)
Exhibit 30: Johnson & Johnson: Business Segmentation by Revenue 2014
Exhibit 31: Johnson & Johnson: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 32: Johnson & Johnson: Sales by Geography 2014
Exhibit 33: Pfizer: Business Segmentation
Exhibit 19: Pfizer: Revenue by Business Segmentation 2014
Exhibit 20: Pfizer: Revenue by Business Segmentation 2013 and 2014 (US$ million)
Exhibit 21: Pfizer: Revenue by Geographical Segmentation 2014
【レポート販売概要】
■ タイトル：急性骨髄性白血病（AML）治療薬の世界市場2015-2019■ 英文：Global Acute Myeloid Leukemia Therapeutics Market 2015-2019
■ 発行日：2014年12月24日
■ 調査会社：Technavio
■ 商品コード：IRTNTR4899
■ 調査対象地域：グローバル
- 直鎖型アルキルベンゼンスルホン酸の世界市場2015Linear Alkyl Benzene Sulfonic Acid (CAS 27176-87-0) Market Research Report 2015 aims at providing comprehensive data on Linear Alkyl Benzene Sulfonic Acid market globally and regionally (Europe, Asia, North America, Latin America etc.) The report includes Linear Alkyl Benzene Sulfonic Acid description, covers its application areas, manufacturing methods, patterns. It captures Linear Alkyl Benzene …
- ロボット用ソフトウェアプラットフォームの世界市場2016-2020About the Robotic Software Platforms Market Robotics software refers to computer programs that simplify the programming of a robot through the use of a unified programming environment, unified service execution environment, and a set of reusable components designed to work in a debugging/simulation environment. Such software also features a set of drivers that can work with common components of ro …
- 導電性インクの世界市場：銀フレーク、誘電性インク、銀ナノ粒子、銅フレーク、炭素ナノ粒子、炭素/グラフェン、導電性ポリマThe global market size of conductive inks is projected to reach USD 3.91 Billion by 2021, registering a CAGR of 3.5% between 2016 and 2021. The growing solar industry in all the regions is expected to majorly drive the conductive inks market during the forecast period. The wide application in solar panels, automotive circuits, and electronic & electrical equipment is also expected to drive the glo …
- 工具用複合材料の世界市場予測（～2021年）：炭素繊維、ガラス繊維、エポキシ樹脂、ビスマレイミド（BMI）The market size of composite tooling is projected to reach USD 551.8 Million by 2021, at a CAGR of 7.35%, between 2016 and 2021. The increasing demand for lightweight and precision tooling of composites in wind, aerospace, automotive, and other applications are the key factors responsible for the growth of the composite tooling market. The global composite tooling market is segmented into type of …
- 整形外科用ナビゲーションシステムの世界市場分析：用途別（背骨、股関節、膝）、地域別（北アメリカ、ヨーロッパ、アジア太平洋、ラテンアメリカ、中東、アフリカ）、セグメント予測、2014-2025The global orthopedic navigation system market is expected to reach USD 303.7 million by 2025, according to a new study by Grand View Research, Inc. Increasing geriatric population prone to orthopedic diseases is a key contributing factor propelling the demand for orthopedic navigation systems over the forecast period. Osteoarthritis and osteoporosis are most common disorders in the population age …
- スマートグリッド市場レビュー：January 2013Smart Grid Review - January 2013 Summary GlobalData announces the release of its monthly smart grid newsletter for January 2013 from the Smart Grid eTrack. The newsletter provides update on the global developments related to smart grid deployment across the globe during the month of December 2012. Scope - Market prospect for companies providing smart grid systems - Key product launch in power grid …
- eラーニングソリューションの世界市場About E-learning E-learning is a learning conducted through internet and other computer devices. It has been widely accepted by both Academic and Non-academic sectors. It is gaining in popularity among corporates as well. Computer-based learning, internet-based learning, and web-based learning are the forms of e-learning. E-learning service providers deliver learning solutions through the latest t …
- 世界のケア管理ソリューション市場：ケア管理ソフトウェア/サービスThe healthcare industry is undergoing a fundamental transformation globally as it shifts from a volume-based business to a value-based business. Growing demands from consumers for improved healthcare quality and greater value are forcing healthcare providers and payers to deliver optimized outcomes. In addition, governments across the globe are increasingly working towards reducing healthcare cost …
- 中国の薬剤溶出型ステント市場About drug eluting stent Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels). Technavio's analysts forecast the drug …
- 鉄道車両の世界市場：ディーゼル機関車、電気機関車About rolling stock Wheeled railway vehicles that move on tracks are referred to as rolling stock. The vehicles primarily include locomotives, passenger rail vehicles, and freight wagons. Some are propelled vehicles and some are self-propelled. These vehicles are capital-intensive products and their manufacturing involves huge investment and long time. Technavio's analysts forecast the global roll …
- 硝酸の世界市場2017-2021About Nitric Acid Nitric acid is used as an intermediate in the manufacture of polyurethane (PU) foams. There is an increasing demand for PU foams in transportation, furniture and bedding, and construction industries. The expanding market for nitric acid is attributed to its extensive use in fertilizers and production of adipic acid, TDI, nitrobenzene, and nitrochlorobenzene. Technavio’s analysts …
- 世界の小売産業におけるM2M市場動向（2012-2016）TechNavio's analysts forecast the Global Cellular M2M market in the Retail industry to grow at a CAGR of 36.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of mobile devices. The Global Cellular M2M market in the Retail industry has also been witnessing various technological advancements. However, the need for high capital …
- 心房細動(Atrial Fibrillation)の治療薬パイプライン動向（2015年上半期版）Atrial Fibrillation - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Atrial Fibrillation - Pipeline Review, H1 2015’, provides an overview of the Atrial Fibrillation’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Atrial Fibrillation, complete with comparative analysis at various stages, therapeutics assessment by drug target, m …
- 世界のメタボロミクス（メタボローム解析）市場（2014-2018）About Metabolomics Metabolomics or Metabonomics is the scientific study of chemical processes involving metabolites. Metabolomics has become a new experimental technique that is being widely used in biology, medicine and the environmental sciences. Metabolites are small molecules that are present in blood, urine, and tissues. The pattern, or fingerprint, of metabolites in a biological sample is us …
- 2014年戦略提言：Salmonella診断検査市場The report presents a detailed analysis of the Salmonella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Salmonella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - P …
